Practice Alert Podcast

COVID-19 vaccines: New candidates & answers to commonly asked questions

J Fam Pract. 2021 March;70(2):audio
By
Doug Campos-Outcalt, MD, MPA
Author and Disclosure Information

Which patients should not get the COVID-19 vaccine because of the risk of anaphylaxis? Can the COVID-19 vaccine be co-administered with other vaccines? Is there flexibility in the timing of the 2-dose regimen for COVID-19 vaccine? Dr. Campos-Outcalt answers these common questions and more. He also describes the newest vaccine candidate to be approved (and the advantages it may offer), and previews a fourth option that’s in the pipeline.

 

REFERENCES

  1. CDC. COVID-19 vaccination. Accessed February 22, 2021.
  2. CDC. COVID data tracker. Accessed February 22, 2021.
  3. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Pfizer-BioNTech COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2020;69:1922-1924. Accessed February 22, 2021.
  4. Oliver SE, Gargano JW, Marin M, et al. The Advisory Committee on Immunization Practices’ interim recommendation for use of Moderna COVID-19 vaccine—United States, December 2020. MMWR Morbid Mortal Wkly Rep. 2021;69:1653-1656. Accessed February 22, 2021.
  5. Gee J, Marquez P, Su J, et al. First month of COVID-19 vaccine safety monitoring—United States, December 14, 2020–January 13, 2021. MMWR Morbid Mortal Wkly Rep. ePub: February 19, 2021. Accessed February 22, 2021.
  6. CDC COVID-19 Response Team; Food and Drug Administration. Allergic reactions including anaphylaxis after receipt of the first dose of Moderna COVID-19 vaccine—United States, December 21, 2020–January 10, 2021. MMWR Morb Mortal Wkly Rep. 2021;70:125-129. Accessed February 25, 2021.

Next Article:

Ivabradine knocks down heart rate, symptoms in POTS